| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/12/2003 | EP1361436A1 Multilayer reagent test strips and methods for using the same to quantify glycated protein in a physiological sample |
| 11/12/2003 | EP1361435A1 Specific binding analyzer and method of analyzing specific binding |
| 11/12/2003 | EP1361434A1 Selectively hybridizable substance immobilization fiber, fiber array compsiring bundle of such fibers, selective hybridizing method, device therefor, and base |
| 11/12/2003 | EP1361432A2 Method and apparatus for determining the cleanliness of metal |
| 11/12/2003 | EP1361431A1 A device for measuring the degree of hardness of the water supplied to a household washing appliance |
| 11/12/2003 | EP1361424A2 Method and apparatus for quantitatively measuring dioxin homologues and isomers by a doppler-free laser spectroscopy |
| 11/12/2003 | EP1361418A1 Tablet alignment apparatus |
| 11/12/2003 | EP1361285A2 Protein kinase peptide substrate determination using peptide libraries |
| 11/12/2003 | EP1361283A1 Novel assay method |
| 11/12/2003 | EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof |
| 11/12/2003 | EP1361270A2 Disruption of the REDK gene |
| 11/12/2003 | EP1361267A2 Mesenchymal stem cells and their use |
| 11/12/2003 | EP1361228A1 Thermostable and monoconjugatable gold cluster complexes |
| 11/12/2003 | EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases |
| 11/12/2003 | EP1360962A2 Interferon tau composition and methods of use |
| 11/12/2003 | EP1360935A1 Strip containing a series of fluid sampling and testing devices and method of making, packaging and using it |
| 11/12/2003 | EP1360934A1 Devices and methods for accessing and analyzing physiological fluid |
| 11/12/2003 | EP1360560A2 Receptor selectivity mapping |
| 11/12/2003 | EP1360515A1 Method and apparatus for detection and measurement of accumulations of magnetic particles |
| 11/12/2003 | EP1360509A1 Preparation of fluid samples by applying pressure |
| 11/12/2003 | EP1360508A2 Prediction of wound healing by urinary nitrate assay |
| 11/12/2003 | EP1360507A2 Vitamin d assay |
| 11/12/2003 | EP1360506A2 Methods for measuring stress in mammals |
| 11/12/2003 | EP1360505A1 Methods and devices for quantitation of glycated protein |
| 11/12/2003 | EP1360504A2 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 11/12/2003 | EP1360503A2 Modulators of p53-p300 interactions and screening methods therefor |
| 11/12/2003 | EP1360502A2 Ligands used for detecting prions |
| 11/12/2003 | EP1360501A2 Method of identifying conformation-sensitive binding peptides and uses thereof |
| 11/12/2003 | EP1360500A2 Methods for selective targeting |
| 11/12/2003 | EP1360499A2 Determination of cytosolic nadp-dependent malate dehydrogenase isoenzyme |
| 11/12/2003 | EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 11/12/2003 | EP1360497A2 Urine assay for ovarian reserve |
| 11/12/2003 | EP1360496A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 11/12/2003 | EP1360495A2 High throughput screening of compounds for biological activity |
| 11/12/2003 | EP1360494A2 Improved non-luminescent substrate |
| 11/12/2003 | EP1360493A1 Screening method using solid supports modified with self-assembled monolayers |
| 11/12/2003 | EP1360492A2 Sample support for chemical and biological samples |
| 11/12/2003 | EP1360491A2 Biochemical method and apparatus for detecting protein characteristics |
| 11/12/2003 | EP1360490A1 Nucleic-acid programmable protein arrays |
| 11/12/2003 | EP1360489A1 Low affinity screening method |
| 11/12/2003 | EP1360488A1 Spatially resolved enzyme-linked assay |
| 11/12/2003 | EP1360486A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 11/12/2003 | EP1360485A2 Diagnostic methods for pompe disease and other glycogen storage diseases |
| 11/12/2003 | EP1360484A1 Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples |
| 11/12/2003 | EP1360483A1 A method for the prediction of molecular interaction networks |
| 11/12/2003 | EP1360482A1 Method of selecting wood for mechanical pulping |
| 11/12/2003 | EP1360480A2 Device and method for detecting the presence of an analyte |
| 11/12/2003 | EP1360478A1 Microsensor and single chip integrated microsensor system |
| 11/12/2003 | EP1360470A2 Drug discovery system with auto-sampler for multicellular organisms in a sorting flow cytometer |
| 11/12/2003 | EP1360378A2 Bottom plate for lysimeters and method for closing lysimeters with a bottom plate |
| 11/12/2003 | EP1360349A1 System and method for screening of nucleation tendency of a molecule in a levitated droplet |
| 11/12/2003 | EP1360336A2 Innate immunity markers for rapid diagnosis of infectious diseases |
| 11/12/2003 | EP1360335A2 Methods for identifying the target of a compound which inhibits cellular proliferation |
| 11/12/2003 | EP1360332A1 Radiative decay engineering |
| 11/12/2003 | EP1360331A2 Vector system used in screening active substances |
| 11/12/2003 | EP1360330A2 Method for detecting dna polymerisation |
| 11/12/2003 | EP1360329A2 Biochemical method and apparatus for detecting genetic characteristics |
| 11/12/2003 | EP1360326A2 Cell based triple readout assay systems for identifying compounds that affect transcription |
| 11/12/2003 | EP1360324A2 Detection of varicella-zoster virus |
| 11/12/2003 | EP1360319A2 Diagnosis of diseases associated with metabolism |
| 11/12/2003 | EP1360318A2 Method of detection by enhancement of silver staining |
| 11/12/2003 | EP1360317A2 Detection of aberrant dna methylation as marker for human cancer |
| 11/12/2003 | EP1360316A2 Dosage adjustement for antibiotics |
| 11/12/2003 | EP1360315A2 Antimicrobial methods and materials |
| 11/12/2003 | EP1360304A2 Enzymes |
| 11/12/2003 | EP1360299A2 The genome of a bifidobacterium |
| 11/12/2003 | EP1360297A2 Ragweed allergens |
| 11/12/2003 | EP1360295A2 Molecules for desease detection and treatment |
| 11/12/2003 | EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 11/12/2003 | EP1360291A2 Human polynucleotides and polypeptides encoded thereby |
| 11/12/2003 | EP1360286A2 Characterization of the gsk-3beta protein and methods of use thereof |
| 11/12/2003 | EP1360282A2 Degradation and detection of tse infectivity |
| 11/12/2003 | EP1360281A2 Regulation of human wee1-like serine/threonine protein kinase |
| 11/12/2003 | EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 11/12/2003 | EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis |
| 11/12/2003 | EP1360276A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 11/12/2003 | EP1360274A1 Detection of micro-organisms |
| 11/12/2003 | EP1360207A2 Protein arrays |
| 11/12/2003 | EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis |
| 11/12/2003 | EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions |
| 11/12/2003 | EP1360199A2 Treatment involving dkk-1 or antagonists thereof |
| 11/12/2003 | EP1360198A2 Novel polypeptides and nucleic acids encoded thereby |
| 11/12/2003 | EP1360197A2 Histidine phosphatase interacting protein with 240kd |
| 11/12/2003 | EP1360007A1 Method for the preparation of optical (bio)chemical sensor devices |
| 11/12/2003 | EP1359941A2 Albumin-based drug delivery system and antimicrobial peptides |
| 11/12/2003 | EP1359937A1 Altered peptide ligands |
| 11/12/2003 | EP1359922A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 11/12/2003 | EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 11/12/2003 | EP1359904A2 P27 prevents cellular migration |
| 11/12/2003 | EP1359839A2 Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor |
| 11/12/2003 | EP1359838A2 Glucose metering system |
| 11/12/2003 | EP1359837A1 Analyte measurement |
| 11/12/2003 | EP1359797A1 Human sphingosine-1-phosphate phosphatase |
| 11/12/2003 | EP1237478B1 Method and device for determining the partial pressure of a gas component in the expiration air of a patient, resolved per respiration |
| 11/12/2003 | EP1166108B1 Method for the separation of fetal cells from the maternal peripheral blood |
| 11/12/2003 | EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 11/12/2003 | EP1105456B1 Fast measuring device of enzymatic activity |
| 11/12/2003 | EP1089800B1 Filtration and extraction device and method of using the same |
| 11/12/2003 | EP1038176B1 Embossed test strip system |
| 11/12/2003 | EP1007961B1 Classifying apparatus designed in particular for odour recognition |